A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

@inproceedings{Li2010API,
  title={A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer},
  author={C Li and J-S Chen and L. T. Tai-Hua Chen and C-J Yen and K-D Lee and W C Su and P-C Lin and C Lu and Hui-Ju Tsai and Y. Chao},
  booktitle={British Journal of Cancer},
  year={2010}
}
Background:Docetaxel plus cisplatin and 5-fluorouracil has become a new standard for treating advanced gastric cancer. However, high rates of severe neutropenia limit its application. Modification of the regimen could be the solution to get similar activity but less myelosuppression.Methods:Patients with histologically confirmed, locally advanced, or… CONTINUE READING